Preoperative atropine in IFIS.
Osher
Robert H
RH
D000317:Adrenergic alpha-Antagonists / Q000009:adverse effects; D000970:Antineoplastic Agents / Q000009:adverse effects*; D001285:Atropine / Q000008:administration & dosage*; D006801:Humans; D007431:Intraoperative Complications / Q000517:prevention & control*; D007498:Iris / Q000187:drug effects*; D007499:Iris Diseases / Q000139:chemically induced / Q000517:prevention & control*; D008297:Male; D009184:Mydriatics / Q000008:administration & dosage*; D009883:Ophthalmic Solutions / Q000008:administration & dosage; D018918:Phacoemulsification; D011300:Preoperative Care; D011470:Prostatic Hyperplasia / Q000188:drug therapy; D013449:Sulfonamides / Q000009:adverse effects*; D013577:Syndrome; D000077409:Tamsulosin
D000317:Adrenergic alpha-Antagonists; D000970:Antineoplastic Agents; D009184:Mydriatics; D009883:Ophthalmic Solutions; D013449:Sulfonamides; D001285:Atropine; D000077409:Tamsulosin